Bacteremia due to Mycobacterium massiliense in a patient with chronic myelogenous leukemia: Case report

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 2, 2012, Pages 183-185

  Hamamoto, Takaaki ^a   Yuki, Atsushi ^a   Naoi, Kenji ^a   Kawakami, Saki ^a   Banba, Yukiharu ^a   Yamamura, Takeshi ^b   Hikota, Reina ^b   Watanabe, Junichi ^b   Kimura, Fumihiko ^b   Nakanaga, Kazue ^c   Hoshino, Yoshihiko ^c   Ishii, Norihisa ^c   Shimazaki, Hideyuki ^a   Nakanishi, Kuniaki ^a   Tamai, Seiichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Bacteremia; Chronic myelogenous leukemia; Mycobacterium massiliense

Indexed keywords

AMIKACIN; ANTIFUNGAL AGENT; BACTERIAL DNA; BCR ABL PROTEIN; BUSULFAN; CLARITHROMYCIN; DASATINIB; ETHAMBUTOL; ETHIONAMIDE; IMATINIB; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MEROPENEM; RIFAMPICIN; STREPTOMYCIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; AUTOPSY; BACTEREMIA; BACTERIUM IDENTIFICATION; BCR ABL GENE; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; DIAGNOSTIC ERROR; DNA DNA HYBRIDIZATION; EMBOLISM; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM MASSILIENSE; ONCOGENE; PRIORITY JOURNAL; SEPTIC EMBOLISM; SEQUENCE ANALYSIS; SPUTUM SMEAR;

BACTEREMIA; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84866158944     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.06.009     Document Type: Article

References (8)

1. Brown-Elliott B.A., Wallace R.J. Principle and practice of infectious diseases 2005, 2909-2915. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell (Ed.).
2. Griffith D.E., Girard W.M., Wallace R.J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993, 147:1271-1278.
3. Han X.Y., De I., Jacobson K.L. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007, 128:612-621.
4. Katoch V.M. Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res 2004, 120:290-304.
5. Koh W.J., Jeon K., Lee N.Y., Kim B.J., Kook Y.H., Lee S.H., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011, 183:405-410.
6. Nakanaga K., Hoshino Y., Era Y., Matumoto K., Kanazawa Y., Tomita A., et al. Multiple cases of cutaneous Mycobacterium massiliense infection in a "hot spa" in Japan. J Clin Microbiol 2010, 49:613-617.
7. Simmon K.E., Pounder J.I., Greene J.N., Walsh F., Anderson C.M., Cohen S., et al. Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States. J Clin Microbiol 2007, 45:1978-1980.
8. Zelazny A.M., Root J.M., Shea Y.R., Colombo R.E., Shamputa I.C., Stock F., et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 2009, 47:1985-1995.